This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Researchers followed chronic pain patients and found something fascinating: the group using just 2.5 A leading researcher in cannabis medicine documented something fascinating called the “biphasic effect.” With cannabis, we’re talking about tiny amounts maybe 1 to 5 milligrams of THC, sometimes even less.
Latest Research and Clinical Studies Now, let’s talk about science! Some research suggests that cannabis could be an effective option for managing anxiety, especially in lower doses. Some research suggests that cannabis could be an effective option for managing anxiety, especially in lower doses. But high doses?
Recent research from 2023 confirms what I see in my practice daily: medical cannabis often provides more comprehensive pain relief than opioids, addressing not just the physical sensation but the emotional toll that chronic pain takes. I recently had a patient, Maria, who’d been on opioids for her fibromyalgia for over a decade.
In 2021, MoreBetter used its web-based software to track over 350 people using a CBN tincture from CBDistillery. In September 2021, MoreBetter hosted a self-reported data collection with this CBN tincture offered to participants for free of charge from CBDistillery. It also, allegedly, helps with sleep (more on that below).
(NYSE American: YCBD, YCBDpA), one of the leading, and most highly trusted and recognized CBD companies, announced today that its recently formed division, cbdMD Therapeutics, has initiated talks with one of the leading US cannabinoid research institutes, to identify novel cannabinoids for therapeutic use. About cbdMD, Inc. cbdMD, Inc.
NM: As someone who has been researching cannabis for decades, how do you feel about the current legalization situation worldwide and in Japan, in particular? Dr. Andrew Weil: I think the trend very clearly is that in most developed countries, cannabis is being made legal first for medical uses and then also for recreational uses.
HHC was synthesized in Adams’ laboratory as part of research to understand the active compounds in the cannabis plant. HHC can be vaped or used in edibles and oils and tinctures (Shutterstock). There are even a few third-party testing labs that are developing analytical methods to test and validate HHC sample identity and purity.
And while there is essentially no research to say what CBGA does when taken by humans, CBGA has undergone preliminary (preclinical) research for its effects in seizures, inflammation, diabetes, and even COVID infections. Pain and inflammation. More studies are needed to fully understand CBGA’s application in inflammation.
Chong told Forbes that after he was cast on Dancing With The Stars, the stress and strain of the dancing built up and led him, in his estimation, to develop rectal cancer as well. In 2016, she helped cofound “Whoopi & Maya,” a business that made wellness products for women, including THC and CBD-rich topicals and tinctures.
This article explores various aspects of using medical marijuana to alleviate neuropathic pain, offering tips and insights based on the latest medical research. Experiment with Different Methods: Try different methods of administration, such as inhalation, edibles, tinctures, and topicals, to find the one that works best for you.
GW Pharma carefully developed Epidiolex using cannabinoids to reduce the occurrence of seizures. Marijuana law reform advocates and many medical researchers have been fighting to change marijuana’s Schedule I classification for years. Schedule I classification typically pertains to narcotic substances with no medical value.
Additionally, no current treatments can reverse existing neurological damage, highlighting the need for ongoing research into more effective therapies and potential cures. Clinical Evidence and Research Findings Research into the efficacy of medical marijuana for MS management has yielded promising results.
It has shown effectiveness in helping individuals develop better sleep habits and manage insomnia symptoms without relying on medication. There are also different methods of consumption available, including edibles, oils, tinctures, and inhalation through smoking or vaping.
Nevertheless hemp was only allowed for medicinal purposes, as was defined in the Act as: “medicinal cannabis”, that is, medicinal hemp, means any extract or tincture of cannabis (hemp); Manufacture of cannabis/hemp seed products is covered under the ambit of Drugs and Cosmetics Act. Recent Development.
We’re actively working toward developing new genetics to work on efficacy and assist the patients in Israel still operating with our nurse-run clinics in order to better provide the right dosage and strains for the patients who are referred to us by the Ministry of Health,” Stephen Gardner, Tikun Olam’s chief marketing officer, tells Freedom Leaf.
Cannabinoids have been shown to have anti-inflammatory effects, which may help reduce the inflammation that can contribute to migraines.Cannabis influences neurotransmitter release, helping to modulate the neural pathways involved in migraine development. More clinicaltrials are needed to establish definitive efficacy and safety profiles.
Both THC and CBD were first isolated in a laboratory in the early 1940s by American researcher Roger Adams. It wasn’t until the 1960s, however, that Israeli researcher Raphael Mechoulam properly identified the chemical structure of CBD, which led to the wealth of knowledge and scope of research we have today. Shutterstock).
Research has found that meditation can potentially have a variety of health benefits , including lowering blood pressure, reducing anxiety and depression, and may even provide some relief from conditions like irritable bowel syndrome and ulcerative colitis. Meditation and mindfulness. How CBD and cannabis products can help.
Research on CBD ( cannabidiol ) shows that it has vast therapeutic properties. The findings were confirmed by similar research conduction in the following year. The findings were confirmed by similar research conduction in the following year. In June of 2019, the FDA in the U.S. In June of 2019, the FDA in the U.S.
As interest in natural health remedies grows, CBD has become a focal point of research into its efficacy in managing anxiety and stress. CBD for Anxiety Management Scientific Research and Studies Numerous studies have investigated CBD’s efficacy in managing anxiety disorders. Image by Suzy Hazelwood on Pexels.
So, no wonder CBD-related products are everywhere in the form of tinctures, gummies, oil, cosmetics, and a lot more. Moreover, the FDA has also allowed researchers to conduct CBD trials. But things have changed after FDA eased out regulations in 2015 to carry out CBD trials. So, there are huge developments after that.
Exploring Different Consumption Methods: Medical marijuana comes in various forms, including flowers, concentrates, edibles, tinctures, and topicals. Veterans can work with their VA healthcare providers to develop personalized treatment plans that address their unique needs and preferences.
Thus, an educational gap developed, creating a less than ideal situation for medical marijuana patients. So, why did this educational gap develop? Unfortunately, this did not occur. Medical marijuana, unlike every other legal medication in the US, has been legalized by the vote of the public and the work of policymakers.
One area of research that has been gaining attention is the use of CBD-rich cannabis in treating the social symptoms of Autism Spectrum Disorder (ASD). Some individuals may have delayed speech development or struggle with expressing their thoughts and emotions effectively. For years, the use of cannabis has been a controversial topic.
The highlights for the quarter are: As previously disclosed, on September 7, 2021, the Company announced the completion of its Phase 1 clinicaltrial on IGC’s tetrahydrocannabinol (“THC”) based investigational new drug, IGC-AD1, intended to alleviate certain symptoms of individuals who have Alzheimer’s disease. Cost of revenue. . .
Based on the product, the market is segmented into oils, tinctures, suppositories, transdermal patches, isolates, tablets, capsules, vape oils, creams and roll-ons, and others. Product Development Via Research and Novel Product Delivery Solutions. Researchers Are Studying New Uses of Medical Marijuana. Opportunities.
Joseph Billions writes for Cannabis Law Report……So much work has gone into fully determining the medical applications of cannabis, endless works of research have been conducted on how this gift of nature can help make the world a better place and so far there have been numerous breakthroughs among which is autism treatment.
In the early 1990s, researchers discovered a previously unknown communication system involved in the regulation of nearly every essential function in the body. They named it the endocannabinoid system (ECS) after the plant elements that led researchers to its discovery cannabinoids.
The 29th annual International Cannabinoid Research Society ( ICRS ) symposium, which convened last month in Bethesda, Maryland, featured new developments in CBD science that have far-reaching implications for many areas of medicine. But would tolerance develop with repeated dosing, thereby mitigating CBD ’s hypotensive effect?
The 29th annual International Cannabinoid Research Society ( ICRS ) symposium, which convened last month in Bethesda, Maryland, featured new developments in CBD science that have far-reaching implications for many areas of medicine. But would tolerance develop with repeated dosing, thereby mitigating CBD ’s hypotensive effect?
The vast majority of the existing research is on how specific cannabinoids kill cancer, but a growing body of work is revealing how the entourage of compounds found in whole-plant cannabis kills cancer. Without increased blood flow, the tumor does not have enough nutrition to sustain its development.
Researchers summarized five key points from the 2020 review : * We estimate that more than 2 million U.S. Few randomized clinicaltrials have been conducted or are planned to explore the effects of marijuana on cardiovascular risk. Instead, the study can be seen as a starting point for discussion and further study. Arrhythmia.
For years, he’d been determined to connect the nascent CBD research he heard about at symposiums abroad with the medical marijuana movement in California. This makes further research very difficult to do, and causes sick people in many states to be treated as criminals. San Francisco weekly. We were in communication for many years.”.
While this research is certainly worth celebrating, the reality behind the message can be easily misunderstood in this age of social media. It seems that every time a positive clinical study relating to cannabis and COVID comes out, the world gets excited about the medical potential of weed as a miracle medicine to end the pandemic.
An alarmingly high number of deaths in many countries has led to researchers scrambling to find an effective treatment or cure for the disease. The researchers suggested looking at it this way: if a cell is like a building with many doors, the virus (untreated) is able to enter through so many of those doors.
Food and beverage makers are gearing up to sell CBD-containing products, when allowed by regulators, including Lagunitas Brewing, which has developed a cannabis-infused IPA and a THC-based sparkling water, and Ben & Jerry’s, which plans to offer a CBD-infused ice cream. billion in 2025, according to Grandview Research.
We organize all of the trending information in your field so you don't have to. Join 14,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content